IS1963B - Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun - Google Patents

Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun

Info

Publication number: IS1963B
Authority: IS; Iceland
Prior art keywords: extract; cartilage; homogenate; shark cartilage; extracts
Prior art date: 1995-02-03

Application number

IS4537A

Other languages

English (en)

Other versions

IS4537A (is

Inventor

Dupont Eric

Brazeau Paul

Juneau Christina

H. Meas Daniel

Marenus Kenneth

Original Assignee

Aeterna Zentaris Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-03

Filing date

1997-08-01

Publication date

2004-12-15

1995-02-03 Priority claimed from US08/384,555 external-priority patent/US5618925A/en

1997-08-01 Application filed by Aeterna Zentaris Inc. filed Critical Aeterna Zentaris Inc.

1997-08-01 Publication of IS4537A publication Critical patent/IS4537A/is

2004-12-15 Publication of IS1963B publication Critical patent/IS1963B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Toxicology (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Birds (AREA)

IS4537A 1995-02-03 1997-08-01 Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun IS1963B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/384,555 US5618925A (en)	1994-04-28	1995-02-03	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
PCT/CA1995/000617 WO1996023512A1 (en)	1995-02-03	1995-10-30	Extracts of shark cartilage, process of production and uses thereof

Publications (2)

Publication Number	Publication Date
IS4537A IS4537A (is)	1997-08-01
IS1963B true IS1963B (is)	2004-12-15

Family

ID=23517788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4537A IS1963B (is)	1995-02-03	1997-08-01	Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun

Country Status (23)

Country	Link
EP (1)	EP0806960B1 (is)
JP (3)	JPH11502514A (is)
KR (1)	KR100347880B1 (is)
CN (1)	CN1138550C (is)
AT (1)	ATE230272T1 (is)
AU (1)	AU717978B2 (is)
BG (1)	BG63801B1 (is)
BR (1)	BR9510540A (is)
CA (1)	CA2212010C (is)
CZ (1)	CZ292627B6 (is)
DE (1)	DE69529300T2 (is)
DK (1)	DK0806960T3 (is)
ES (1)	ES2188672T3 (is)
FI (1)	FI117376B (is)
HU (1)	HU222088B1 (is)
IS (1)	IS1963B (is)
MX (1)	MX9705894A (is)
NO (1)	NO318950B1 (is)
NZ (1)	NZ294553A (is)
PL (1)	PL188137B1 (is)
RO (1)	RO117590B1 (is)
RU (1)	RU2157695C2 (is)
WO (1)	WO1996023512A1 (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025334A (en) *	1994-04-28	2000-02-15	Les Laboratoires Aeterna Inc.	Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6380366B1 (en)	1994-04-28	2002-04-30	Les Laboratoires Aeterna Inc.	Shark cartilage extract:process of making, methods of using and compositions thereof
AU724654B2 (en) *	1995-04-21	2000-09-28	Aeterna Zentaris Inc.	Extracts of shark cartilage
AU6639898A (en)	1997-02-20	1998-09-09	Industrial Research Limited	Angiogenesis inhibitors and activators from shark cartilage
IL131701A (en) *	1997-03-11	2005-03-20	Aeterna Zentaris Inc	Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
WO1999002548A1 (en) *	1997-07-11	1999-01-21	Cv Technologies Inc.	A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
AUPO920597A0 (en) *	1997-09-16	1997-10-09	Micronized Foods Pty Ltd	Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
US20020009501A1 (en) *	1998-07-23	2002-01-24	Eric Dupont	Preparation of cartilage extracts using organic solvents
US6168807B1 (en)	1998-07-23	2001-01-02	Les Laboratoires Aeterna Inc.	Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
CN1064690C (zh) *	1998-09-10	2001-04-18	中国人民解放军海军医学研究所	鲨鱼软骨血管生成抑制因子及其分离纯化方法
US6248341B1 (en) *	2000-01-14	2001-06-19	Color Access, Inc.	Method of treating topical angiogenesis-related disorders
WO2001078674A1 (en) *	2000-04-18	2001-10-25	Ceteris Holding B.V. -Amsterdam (Olanda)- Succursale Di Lugano	A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles
KR20030070013A (ko) *	2000-12-20	2003-08-27	인더스트리얼 리서치 리미티드	상어육 추출물
US20070010430A1 (en) *	2003-03-20	2007-01-11	Hosokawa Micron Corparation	Proteoglycan isolated from cartilaginous fish and process for producing the same
ES2223291B1 (es) *	2003-08-06	2006-03-16	Bioiberica, S.A.	Nuevo uso terapeutico de condroitin sulfato.
US7205006B2 (en) *	2003-09-25	2007-04-17	Prime Pharmaceutical Corporation	Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
CN100377741C (zh) *	2004-02-23	2008-04-02	江卫世	注射用复方骨肽及其制备工艺
US20070248930A1 (en)	2005-02-17	2007-10-25	Biolux Research Ltd.	Light therapy apparatus and methods
WO2012075584A1 (en)	2010-12-08	2012-06-14	Biolux Research Limited	Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
WO2013133873A2 (en) *	2011-12-04	2013-09-12	Liu David L	Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy
RU2489906C1 (ru) *	2012-04-18	2013-08-20	Тамара Ивановна Николаева	Биологически активная добавка к пище на основе денатурированного коллагена
US20130287859A1 (en) *	2012-04-26	2013-10-31	Lescarden Inc.	Method for treating prupritus with cartilage extract
DE102012023927A1 (de) *	2012-12-06	2014-06-12	Heinrich Huber	Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung
CN111330163A (zh)	2013-10-22	2020-06-26	碧乐生物光子科研控股有限公司	口腔内光疗法装置以及使用它们的方法
CN106492065A (zh) *	2016-10-20	2017-03-15	王凯茜	一种治疗风湿热的中药
KR102369902B1 (ko) *	2021-04-23	2022-03-02	이수한	전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4822607A (en) *	1976-10-29	1989-04-18	Lescarden Ltd.	Anti-tumor agent and method
US4473551A (en) *	1982-08-23	1984-09-25	Faxon Pharmaceuticals, Inc.	Anti-inflammatory composition
US5075112A (en) *	1990-02-12	1991-12-24	Cartilage Technologies Inc.	Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5618925A (en) *	1994-04-28	1997-04-08	Les Laboratories Aeterna Inc.	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

1995
- 1995-10-30 DK DK95935309T patent/DK0806960T3/da active
- 1995-10-30 CA CA002212010A patent/CA2212010C/en not_active Expired - Fee Related
- 1995-10-30 DE DE69529300T patent/DE69529300T2/de not_active Expired - Fee Related
- 1995-10-30 EP EP95935309A patent/EP0806960B1/en not_active Expired - Lifetime
- 1995-10-30 BR BR9510540A patent/BR9510540A/pt not_active Application Discontinuation
- 1995-10-30 PL PL95321678A patent/PL188137B1/pl not_active IP Right Cessation
- 1995-10-30 RO RO97-01452A patent/RO117590B1/ro unknown
- 1995-10-30 HU HU9800065A patent/HU222088B1/hu not_active IP Right Cessation
- 1995-10-30 KR KR1019970705335A patent/KR100347880B1/ko not_active Expired - Fee Related
- 1995-10-30 WO PCT/CA1995/000617 patent/WO1996023512A1/en active IP Right Grant
- 1995-10-30 ES ES95935309T patent/ES2188672T3/es not_active Expired - Lifetime
- 1995-10-30 CN CNB951977598A patent/CN1138550C/zh not_active Expired - Fee Related
- 1995-10-30 JP JP8523128A patent/JPH11502514A/ja active Pending
- 1995-10-30 CZ CZ19972452A patent/CZ292627B6/cs not_active IP Right Cessation
- 1995-10-30 AT AT95935309T patent/ATE230272T1/de not_active IP Right Cessation
- 1995-10-30 NZ NZ294553A patent/NZ294553A/xx unknown
- 1995-10-30 AU AU37388/95A patent/AU717978B2/en not_active Ceased
- 1995-10-30 RU RU97114752/14A patent/RU2157695C2/ru not_active IP Right Cessation
1997
- 1997-08-01 MX MX9705894A patent/MX9705894A/es not_active IP Right Cessation
- 1997-08-01 NO NO19973564A patent/NO318950B1/no unknown
- 1997-08-01 IS IS4537A patent/IS1963B/is unknown
- 1997-08-01 FI FI973195A patent/FI117376B/fi not_active IP Right Cessation
- 1997-09-01 BG BG101870A patent/BG63801B1/bg unknown
2003
- 2003-02-05 JP JP2003028771A patent/JP2003246742A/ja active Pending
2006
- 2006-07-31 JP JP2006208897A patent/JP2006290904A/ja active Pending

Also Published As

Publication number	Publication date
FI117376B (fi)	2006-09-29
CZ245297A3 (cs)	1998-01-14
ES2188672T3 (es)	2003-07-01
BG101870A (en)	1998-04-30
NZ294553A (en)	1999-07-29
BR9510540A (pt)	1998-06-09
DK0806960T3 (da)	2003-04-22
DE69529300T2 (de)	2003-07-03
PL321678A1 (en)	1997-12-22
NO318950B1 (no)	2005-05-30
FI973195A0 (fi)	1997-08-01
RO117590B1 (ro)	2002-05-30
MX9705894A (es)	1998-07-31
DE69529300D1 (de)	2003-02-06
KR100347880B1 (ko)	2002-12-02
IS4537A (is)	1997-08-01
CA2212010A1 (en)	1996-08-08
CN1177927A (zh)	1998-04-01
PL188137B1 (pl)	2004-12-31
WO1996023512A1 (en)	1996-08-08
FI973195L (fi)	1997-10-01
CN1138550C (zh)	2004-02-18
HUT77488A (hu)	1998-05-28
RU2157695C2 (ru)	2000-10-20
AU3738895A (en)	1996-08-21
JPH11502514A (ja)	1999-03-02
CZ292627B6 (cs)	2003-11-12
JP2003246742A (ja)	2003-09-02
EP0806960B1 (en)	2003-01-02
BG63801B1 (bg)	2003-01-31
NO973564L (no)	1997-10-01
JP2006290904A (ja)	2006-10-26
EP0806960A1 (en)	1997-11-19
ATE230272T1 (de)	2003-01-15
NO973564D0 (no)	1997-08-01
CA2212010C (en)	2004-08-17
AU717978B2 (en)	2000-04-06
HU222088B1 (hu)	2003-04-28

Publication	Publication Date	Title
IS2017B (is)	2005-06-15	Seyði úr hákarlabrjóski
IS4537A (is)	1997-08-01	Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun
FI964327A (fi)	1996-12-20	Hainrusto uutteet joilla on antiangiogeenista aktiivisuutta ja vaikutusta kasvainregressioon; menetelmä niiden valmistamiseksi
MX9306960A (es)	1995-01-31	Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
AUPM534794A0 (en)	1994-05-19	Modified milk growth factor
ATE151774T1 (de)	1997-05-15	Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
EP0635009A1 (en)	1995-01-25	DERIVATIVES OF 2,3-DIHYDRO-2,2,4,6,7-PENTAALKYL-5-BENZOFURANES.
BR9307592A (pt)	1999-08-31	Método e aparelhagem para desidratar produtos biológicos e produtos biológicos desidratados
ATE128354T1 (de)	1995-10-15	Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.